Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

JTC rejects Permira takeover proposals

(Sharecast News) - JTC said on Friday that it had rejected two takeover proposals from private equity firm Permira. The fund administration services provider rejected a non-binding proposal from Permira on 20 August.

It received a second preliminary and conditional non-binding proposal on 22 August which was rejected on 27 August after careful consideration with its advisers.

"Shareholders are advised to take no action at this time in relation to the Permira possible offer," JTC said.

"There can be no certainty that any firm offer will be made for the company, nor as to the terms on which any such offer might be made."

It added that further announcements will be made as and when appropriate.

Under UK takeover rules, Permira has until 26 September to either announce a firm intention to make an offer or walk away.

JTC did not disclose any financial details but earlier on Friday, Bloomberg cited people with knowledge of the matter as saying that Permira had made a proposal that values the company at around £2bn.

At 1410 BST, the shares were up 13.5% at 1,112p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.